Separate names with a comma.
$17 looks like the line here, are you seeing good support there?
CB 2679d/ISU304, a highly potent next-generation coagulation Factor IX variant, has demonstrated the potential to normalize human Factor IX levels...
BOOM! +220%
LULU getting a lot of competition in the sector, its not the standout brand it used to be 5yrs ago.
Ah, here it is: Trump said Ford will make ‘major investment’ at three Michigan auto plants In an early morning tweet, President Trump said Ford...
Next week! :D
-4% at the open, how long before we see the teens?
CCL coming out with good numbers this morning, stock up premarket
TSLA has a $190 target from Goldman Sachs, but then there is also the buy side analysts at Goldman pushing these deals... what a world! :D TSLA...
Did he say something about Ford recently?
Elon Musk wants to connect brains to computers with new company Tesla and SpaceX founder Elon Musk is launching a new company called Neuralink...
Calithera to Receive $12 Million Milestone Payment From Incyte for Achievement of Pharmacokinetic and Pharmacodynamic Goals in Phase 1 Study “We...
Calithera Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule drugs directed...
+5% pre market on news: Tesaro Secures FDA Nod for Ovarian Cancer Drug Tesaro Inc. (TSRO) has announced that it has secured an early approval...
Lots of buzz around TSLA this morning, also interesting news yesterday about Musk getting into the neural human to machine interface sci-fi type...
China’s Tencent Buys 5% Stake in Tesla
Cara Therapeutics Inc. shares CARA, +12.95% surged 16% in premarket trade Tuesday, after the biotech reported positive results in a trial of a...
20.65, nice move so far!
Impax Laboratories (IPXL) shares were up Monday as a former Actavis Specialty Pharmaceuticals executive takes the helm at the company as president...
Impax Laboratories, Inc., a specialty pharmaceutical company, develops, manufactures, and markets bioequivalent pharmaceutical products. It...
